Page last updated: 2024-10-16

bromide and Parkinson Disease

bromide has been researched along with Parkinson Disease in 1 studies

Bromides: Salts of hydrobromic acid, HBr, with the bromine atom in the 1- oxidation state. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed)

Parkinson Disease: A progressive, degenerative neurologic disease characterized by a TREMOR that is maximal at rest, retropulsion (i.e. a tendency to fall backwards), rigidity, stooped posture, slowness of voluntary movements, and a masklike facial expression. Pathologic features include loss of melanin containing neurons in the substantia nigra and other pigmented nuclei of the brainstem. LEWY BODIES are present in the substantia nigra and locus coeruleus but may also be found in a related condition (LEWY BODY DISEASE, DIFFUSE) characterized by dementia in combination with varying degrees of parkinsonism. (Adams et al., Principles of Neurology, 6th ed, p1059, pp1067-75)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Liu, RR1
Zhai, HL1
Zhu, M1
Shao, HP1
Wang, TH1

Other Studies

1 other study available for bromide and Parkinson Disease

ArticleYear
Inhibitory mechanism of n-MTAB AuNPs for α-synuclein aggregation.
    Journal of molecular modeling, 2023, Mar-21, Volume: 29, Issue:4

    Topics: alpha-Synuclein; Bromides; Gold; Humans; Metal Nanoparticles; Parkinson Disease

2023